Lv52
908 积分 2024-08-20 加入
Evaluation of Anti-LGR5 Antibodies by ImmunoPET for Imaging Colorectal Tumors and Development of Antibody–Drug Conjugates
15天前
已完结
LGR5-Targeted Antibody–Drug Conjugate Eradicates Gastrointestinal Tumors and Prevents Recurrence
15天前
已完结
Bispecific antibodies pin down cancer stem cells
19天前
已完结
Functional patient-derived organoid screenings identify MCLA-158 as a therapeutic EGFR × LGR5 bispecific antibody with efficacy in epithelial tumors
19天前
已完结
Navicixizumab plus Paclitaxel Shows Clinical Benefit in Platinum-Resistant Ovarian Cancer
1个月前
已关闭
Ligand-Dependent Notch Signaling in Vascular Formation
1个月前
已完结
Analytical Similarity of a Proposed Biosimilar BVZ-BC to Bevacizumab
2个月前
已完结
Evaluation of Double Self-Immolative Linker-Based Antibody–Drug Conjugate FDA022-BB05 with Enhanced Therapeutic Potential
2个月前
已完结
Effects of Drug–Antibody Ratio on Pharmacokinetics, Biodistribution, Efficacy, and Tolerability of Antibody–Maytansinoid Conjugates
3个月前
已完结
Impact of Drug Conjugation and Loading on Target Antigen Binding and Cytotoxicity in Cysteine Antibody–Drug Conjugates
3个月前
已完结
皖公网安备34019202002308
